{"id":237666,"date":"2026-09-09T12:57:19","date_gmt":"2026-09-09T07:27:19","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=237666"},"modified":"2026-09-09T12:57:19","modified_gmt":"2026-09-09T07:27:19","slug":"astrazeneca-pharma-india-q2-results-fy27-preview-date-expectations","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-q2-results-fy27-preview-date-expectations\/","title":{"rendered":"AstraZeneca Pharma India Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter"},"content":{"rendered":"

AstraZeneca Pharma India share price Rs 6,818.00 on 9 September 2026, down 0.84%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 38.00 crore. Q2 FY26 base a profit of Rs 54.00 crore.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The AstraZeneca Pharma India Q2 results date for FY27 is not confirmed, and AstraZeneca Pharma India Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published within 45 days of the quarter end, an outer deadline of 14 November 2026. The quarter will be measured against a September 2025 base of Rs 559.00 crore in revenue and a profit of Rs 54.00 crore. This preview uses reported actuals only and carries no estimated revenue or profit figure for the coming quarter.<\/p>\n<\/p><\/div>\n

The AstraZeneca Pharma India Q2 results FY27 announcement is the next scheduled earnings event for AstraZeneca Pharma India Ltd.<\/a>, the Indian arm of AstraZeneca, importing, marketing and distributing patented oncology, cardiovascular, metabolic and respiratory prescription medicines to hospitals and doctors. The stock traded at Rs 6,818.00 on the NSE on 9 September 2026, down 0.84% from the previous close of Rs 6,875.50, about 30.8% below its 52-week high of Rs 9,849.50 and 0.0% above its 52-week low of Rs 6,815.00.<\/p>\n

What makes the AstraZeneca Pharma India Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 559.00 crore of revenue and a profit of Rs 54.00 crore, while the most recent quarter on record, Q1 FY27, produced Rs 683.00 crore and a profit of Rs 38.00 crore. Everything below is built from those reported figures rather than from any forecast.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n